Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-016318
Filing Date
2024-12-17
Accepted
2024-12-17 07:00:27
Documents
82
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-K epix-20240930x10k.htm   iXBRL 10-K 1654898
2 EX-10.3 epix-20240930xex10d3.htm EX-10.3 23554
3 EX-10.13 epix-20240930xex10d13.htm EX-10.13 67935
4 EX-19.1 epix-20240930xex19d1.htm EX-19.1 122081
5 EX-21.1 epix-20240930xex21d1.htm EX-21.1 8185
6 EX-23.1 epix-20240930xex23d1.htm EX-23.1 5640
7 EX-31.1 epix-20240930xex31d1.htm EX-31.1 7291
8 EX-31.2 epix-20240930xex31d2.htm EX-31.2 7254
9 EX-32.1 epix-20240930xex32d1.htm EX-32.1 11632
10 EX-97 epix-20240930xex97.htm EX-97 42924
11 GRAPHIC epix-20240930x10k002.jpg GRAPHIC 42646
12 GRAPHIC epix-20240930x10k003.jpg GRAPHIC 37550
13 GRAPHIC epix-20240930x10k004.jpg GRAPHIC 17235
14 GRAPHIC epix-20240930x10k005.jpg GRAPHIC 42272
15 GRAPHIC epix-20240930xex23d1001.jpg GRAPHIC 9914
16 GRAPHIC epix-20240930xex23d1002.jpg GRAPHIC 10247
  Complete submission text file 0001558370-24-016318.txt   7060317

Data Files

Seq Description Document Type Size
17 EX-101.SCH epix-20240930.xsd EX-101.SCH 40903
18 EX-101.CAL epix-20240930_cal.xml EX-101.CAL 44991
19 EX-101.DEF epix-20240930_def.xml EX-101.DEF 115910
20 EX-101.LAB epix-20240930_lab.xml EX-101.LAB 358964
21 EX-101.PRE epix-20240930_pre.xml EX-101.PRE 254358
85 EXTRACTED XBRL INSTANCE DOCUMENT epix-20240930x10k_htm.xml XML 1016364
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37410 | Film No.: 241553632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)